{
    "nct_id": "NCT06623305",
    "official_title": "Photobiomodulation Therapy for the Prevention and Treatment of Mucositis in Pediatric Oncology Patients",
    "inclusion_criteria": "* Admitted to oncology unit, PICU, or on an alternate acute care unit.\n* Diagnosis:\n* Following diagnoses until achieve count recover (ANCâ‰¥500), the patient has no clinical signs of mucositis, or is discharged i. ALL interim-maintenance high dose Methotrexate ii. ALL with trisomy 21 receiving high dose Methotrexate iii. AML iv. Neuroblastoma (excluding admissions for antibody treatment) v. Burkitt lymphoma vi. Osteosarcoma receiving high dose Methotrexate vii. Germ cell tumors receiving Etoposide viii. Rhabdomyosarcoma ix. Ewing sarcoma\n* Head/neck cancers receiving radiation\n* Able to speak and understand English or Spanish\nHealthy volunteers allowed\nMust have maximum age of 30 Years",
    "exclusion_criteria": "* Unwilling to participate\n* Do not meet eligibility criteria outline above",
    "miscellaneous_criteria": ""
}